CEOs Should Keep A Low Profile During Government Inquiries – Consultant
This article was originally published in The Tan Sheet
Executive Summary
Pharmaceutical company CEOs should resist the temptation to mount a personal public relations defense of their firms in response to a government investigation, industry consultant Davia Temin said recently at the Pharmaceutical Compliance Forum in Washington, D.C